Logo Image
News|Videos|May 19, 2025

Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill

Fact checked by: Todd Shryock

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

There are three criteria for compounding pharmacists to mix a version of a medicine that is not available from a pharmaceutical manufacturer. Scott Brunner, CEO of the Alliance for Pharmacy Compounding offers this tutorial and examples of how compounding pharmacists meet patient demand for necessary drugs.

Related Content

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more